CGEM – cullinan oncology, inc. (US:NASDAQ)
Stock Stats
News
Cullinan Therapeutics (NASDAQ:CGEM) was downgraded by analysts at Wall S
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Wall Str
Form SCHEDULE 13G Cullinan Therapeutics, Filed by: VANGUARD GROUP INC
Form 4 Cullinan Therapeutics, For: Jan 22 Filed by: Michaelson Jennifer
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
Form 8-K Cullinan Therapeutics, For: Jan 08
Form 4 Cullinan Therapeutics, For: Dec 31 Filed by: Fenton Mary Kay
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.